ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2517

Skin Microbiome Shows Differences Between Pathergy Positive and Negative Patients with Behçet’s Syndrome

Betul Sarac1, Ayse Kalkanci2, Esra Kilic2, Elif Ayca Sahin2, Yesim Ozguler3 and Gulen Hatemi3, 1Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Istanbul, Turkey, 2Gazi University, Faculty of Medicine, Department of Medical Microbiology, Ankara, Turkey, 3Istanbul University-Cerrahpasa, Cerrahpasa Medical Faculty, Department of Internal Medicine, Division of Rheumatology, Istanbul, Turkey

Meeting: ACR Convergence 2024

Keywords: Behçet's Syndrome, microbiome

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Vasculitis – Non-ANCA-Associated & Related Disorders Poster III

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Gut, oral and genital mucosa microbiome studies in Behçet’s syndrome have shown heterogeneous results including reduced bacterial diversity and decrease in butyrate-producing bacteria. A role of microorganisms and/or microbial products in pathergy positivity was proposed based on decreased positivity after surgical cleaning and increased positivity when patient’s saliva and pneumococcal vaccine are applied to the pathergy site. We aimed to determine the skin microbiome of pathergy positive and negative patients with Behçet’s syndrome.

Methods: We compared the bacterial and fungal skin microbiome of 30 pathergy positive and 30 pathergy negative patients who were not treated with immunosupprresives. Skin samples were obtained by swabbing before the pathergy test and stored at -80oC. The first 30 pathergy positive patients and 30 pathergy negative patients matched to the pathergy positive ones for demographic features were included. Samples were studied using 16S and 5.8S rRNA gene sequencing.

Results: Bacterial diversity within each group (alpha diversity) was similarly high in both groups. Beta diversity analysis revealed that the bacteria in the two groups were different from each other in terms of genus and species. The pathergy negative group was rich in Betaproteobacteria, Burkholderiales, and Ralstonia picketti, while the pathergy positive group showed enrichment in Nevskia soli, Staphylococcus haemolyticus, and Sphingomonas sanxanigenens.  Alpha diversity of fungal species was higher in the pathergy positive group. Beta diversity analysis showed that the fungi of both groups were similar. Pseudopezicula tracheiphila and Aspergillus heterocaryoticus were the most abundant fungi in the pathergy positive group, while Aspergillus subversicolor prevailed in the pathergy negative group.

Conclusion: The skin microbiota was different among pathergy positive and negative BS patients. Bacterial diversity was high and bacterial species were different among the two groups. Fungal diversity was higher in the pathergy positive group and there were similar fungi in terms of genus in both groups. The role of these differences in pathergy positivity needs to be further studied.


Disclosures: B. Sarac: None; A. Kalkanci: None; E. Kilic: None; E. Sahin: None; Y. Ozguler: None; G. Hatemi: Abbvie, 2, AbbVie/Abbott, 6, Boehringer-Ingelheim, 6, Novartis, 6, Pfizer, 2, UCB, 6.

To cite this abstract in AMA style:

Sarac B, Kalkanci A, Kilic E, Sahin E, Ozguler Y, Hatemi G. Skin Microbiome Shows Differences Between Pathergy Positive and Negative Patients with Behçet’s Syndrome [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/skin-microbiome-shows-differences-between-pathergy-positive-and-negative-patients-with-behcets-syndrome/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/skin-microbiome-shows-differences-between-pathergy-positive-and-negative-patients-with-behcets-syndrome/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology